DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202733

Polycystic ovary syndrome risk: efficacy of self-assessment test

Jyoti Taneja, Taruna Arora, Anju Jain, Chandra Mansukhani, Latika Bhalla, Sarita Nanda

Abstract


Background: Polycystic ovary syndrome (PCOS) is a growing morbidity in young women globally. This disease has an association with several exogenous factors like irregularity of menses, hirsutism and obesity. Very few standardized self-assessment tools based on easily observable factors are available for use in the Indian population, which can help them to assess their PCOS risk accurately.

Methods: Undergraduate women of the age group 18-22 years enrolled in a university campus participated in the survey questionnaire. Nineteen questions with binary answers as “yes” or “no” were used for self-assessment test. Each “yes” was scored as one mark, and each “no” scored as zero, leading to the maximum score of 19. Scores of the women with irregular menses (test group) were compared to those of regular menses (control group). Welch’s corrected t-test was used to calculate the significance at 5% between the groups. The clinical assessment confirmed the presence or absence of PCOS condition.

Results: One thousand and fifty-four women participated in the study. The study showed that 262 (24.8%) of young women reported irregular menstrual cycle. The average total score of the control group was 3.07±2.35, whereas that of the women with irregular menses was 5.93±2.86. 21 out of 28 participants, who scored high, were diagnosed with PCOS, on clinical assessment by Rotterdam criteria.

Conclusions: The self-assessment test can assess the risk of PCOS. This test has 75% sensitivity and accuracy in predicting the presence of PCOS.


Keywords


Menstrual cycle disorder, Polycystic ovary syndrome, Premenstrual syndrome, Survey, Women's health issues

Full Text:

PDF

References


World Health Organization. Women and health: today’s evidence tomorrow’s agenda. World Health Organization 2009. Available at: https://www.who.int/gender-equity-rights/knowledge /9789241563857/en/. Accessed on 6th May 2020.

Polycystic ovary syndrome. Available at: https://www.nhp.gov.in/disease/endocrinal/ovaries/polycystic-ovary-syndrome-pcos. Accessed on 3rd May 2020.

Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013;17(1):138-45.

Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351-8.

Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.

Ozdemir S, Ozdemir M, Görkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199-204.

March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544-51.

McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med. 2016;375(1):54-64.

Zhao H, Lv Y, Li L, Chen ZJ. Genetic studies on polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2016;37:56-65.

Yang Q, Zhao Y, Qiu X, Zhang C, Li R, Qiao J. Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study. Hum Reprod. 2015;30(8):1964-73.

Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27-36.

Sedighi S, Akbari SA, Afrakhteh M, Esteki T, Majd HA, Mahmoodi Z. Comparison of lifestyle in women with polycystic ovary syndrome and healthy women. Glob J Health Sci. 2015;7(1):228-34.

Jaya P, Shailesh R. Polycystic ovarian syndrome (PCOS) awareness among young women of central India. Int J Reprod Contracept Obstet Gynecol. 2018;7(10):3960-4.

Pitchai P, Sreeraj SR, Anil PR. Awareness of lifestyle modification in females diagnosed with the polycystic ovarian syndrome in India: an explorative study. Int J Reprod Contracept Obstet Gynecol. 2016;5(2):470-6.

Bergh CM, Moore M, Gundell C. Evidence-based management of infertility in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2016;45(1):111-22.

Brassard M, AinMelk Y, Baillargeon JP. Basic infertility, including polycystic ovary syndrome. Med Clin North Am. 2008;92(5):1163-92.

Dokras A, Bochner M, Hollinrake E, Markham S, VanVoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106(1):131-7.

Gambineri A, Patton L, Altieri P. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term perspective study. Diabetes. 2012;61(9):2369-23674.

Aziz M, Sidelmann JJ, Faber J, Wissing ML, Naver KV, Mikkelsen et al. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes. Acta Obstet Gynecol Scand. 2015;94(10):1082-9.

Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782-5.

Okamura Y, Saito F, Takaishi K. Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age. Reprod Med Biol. 2017;16(1):67-71.

Warren-Ulanch J, Arslanian S. Treatment of PCOS in adolescence. Best Pract Res Clin Endocrinol Metab. 2006;20(2):311-30.

Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol. 2002;13(6):251-7.

Moran LJ, Brinkworth G, Noakes M, Norman RJ. Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online. 2006;12(5):569-78.

Kite C, Lahart IM, Afzal I, Broom DR, Randeva H, Kyrou, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev. 2019;8(1):51.

Malik S, Jain K, Talwar P. Management of polycystic ovary syndrome in India. Fertil Sci Res. 2014;1(1):23-43.

Pedersen SD, Brar S, Faris P, Corenblum B. Polycystic ovary syndrome: validated questionnaire for use in diagnosis. Can Fam Physician. 2007;53(6):1041-7.

Kumarapeli V, Seneviratne RD, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Sri Lanka. Am J Epidemiol. 2008;168(3):321-8.

Vliet EL. PCOS Questionnaire. 1995. Available at: https://www.herplace.com/hormone-info/PCOSQuestionnaire.pdf. Accessed on 6th May 2020.

Sweet MG, Schmidt-Dalton TA, Weiss PM, Madsen KP. Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician. 2012;85(1):35-43.